Why the study?
Does remote monitoring improve diagnosis times and reduce in-office visits in patients with pacemakers and implantable defibrillators compared to standard follow-up?
Does remote monitoring improve diagnosis times and reduce in-office visits in patients with pacemakers and implantable defibrillators compared to standard follow-up?
Remote monitoring of cardiac devices reduces in-office visits and accelerates the diagnosis of critical events, establishing it as a standard of care.
Supports remote monitoring to reduce visits and speed diagnoses in device patients; leaves open need for prospective RCTs to confirm.
Modern pacemakers and implantable defibrillators are able to automatically perform tests executed manually during in-office visits; such as measurement of sensing and pacing thresholds. In addition, the devices also record a wealth of diagnostic data that are of clinical relevance. The advent of wireless technology in these devices allows automatic transmission of these data that can be consulted remotely by the physician. There is now solid evidence indicating that remote device follow-up can safely reduce the number of in-office visits, thereby improving convenience for patients and caregivers alike. Remote monitoring with automatic alerts for arrhythmias, heart failure and technical issues, has been shown to dramatically reduce delay to diagnosis of these events compared with standard follow-up; potentially improving patient safety and outcome. For these reasons, remote device management is becoming the standard of care.
No takes yet. Share an insight, caveat, or question.
Haran Burri (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: